Subspecialties

UK Eye Doctor Christopher Brand speaks at the EURETINA conference in September 2015

Results from the INTREPID study show that, in eyes with neovascular AMD, a single treatment of stereotactic radiotherapy with the Oraya Therapy can significantly reduce intravitreal injections over two years of follow-up while maintaining vision. Supplement includes authors Tim Jackson, PhD, FRCOphth; Frank Zimmerman, MD; Mahdy Ranjbar, MD; Katja Hatz, MD; and Christopher Brand, FRCOphth.

Highlights from Bayer’s Satellite Symposium ‘Eylea®(aflibercept solution for injection) for Visual Impairment due to Diabetic Macular Edema: Every Letter Matters, Every Day,’ held on September 18, 2015, at the 15th EURETINA Congress, Nice, France

How the OS4® and HDC Control Take Your Vitreoretinal Surgery to the Next Level

How is the IC-8 small-aperture IOL performing in the real world?

Assessing and successfully treating iris defects can be a challenge, but the right techniques and tools can greatly improve the outcomes

Ascorbic acid testing could provide fast information on the severity of ocular injuries and postsurgical complications at the point-of-care

Patients with myopia often get poorer results from accommodating IOLs than those without – and a recent study explains why

For retina stem cell researchers, growing and purifying lots of RGCs from hPSCs has been hard… until now

Marine mammals have tear films filled with interesting antimicrobial agents – and understanding the compounds present might one day lead to new antibiotic drugs